Evidence map›Paper›PMID 41249784›Full record

ArticleNPJ vaccines2025

Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA stability.

Ayoung Oh, Seonghyun Lee, Hyeong-Jun Park, Subin Yoon, Dahyeon Ha, Jisun Lee, Sowon Lee, Gahyun Roh, Youngran Cho, Soo-Yeon Lee and 9 more

Abstract read
In one paragraph

Article in NPJ vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ayoung Oh *Department of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Seonghyun Lee *Department of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Hyeong-Jun Park *SML Biopharm, Gyeonggi-do, Gwangmyeong, Republic of Korea.
Subin YoonDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Dahyeon HaDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Jisun LeeDepartment of Medical and Biological Sciences, The Catholic University of Korea, Bucheon, Republic of Korea.
Sowon LeeDepartment of Medical and Biological Sciences, The Catholic University of Korea, Bucheon, Republic of Korea.
Gahyun RohDepartment of Medical and Biological Sciences, The Catholic University of Korea, Bucheon, Republic of Korea.
Youngran ChoDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Soo-Yeon LeeDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Eun-Jin ChoiDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Yeeun LeeDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Seo-Hyeon BaeDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Seongje ChoDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Huijeong ChoiDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Sohee JoDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Jungmin KimDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Hyo-Jung ParkBK21 Four Department of Biotechnology, The Catholic University of Korea, Gyeonggi-do, Bucheon, Republic of Korea.
Jae-Hwan NamDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea. jhnam@catholic.ac.kr.

Funding

Korea Disease Control and Prevention Agency 2023-ER1701-00Ministry of Food and Drug Safety 22213MFDS421
6 · The paper itself

Abstract

As mRNA technology emerges as a groundbreaking innovation, an increasing number of studies are attempting to increase expression levels by optimizing the structure of mRNA, such as the 5' or 3' untranslated regions (UTR). We designed a novel loop structure in the poly(A) tail of an mRNA platform to improve the stability and duration. Protein expression analyses were conducted using bioluminescence, both in vitro and in vivo. Additionally, cellular and humoral responses to different antigens were confirmed using flow cytometry and ELISA of splenocytes and serum isolated from mice immunized with mRNA containing different poly(A) tail structures. The poly(A) tail with a loop structure exhibited higher bioluminescence signals, both in vitro and in vivo, and increased human erythropoietin (hEPO) expression in vivo compared to the other poly(A) tail groups. This indicates that the addition of a loop structure to the poly(A) tail region improves mRNA stability and efficiency. The results of analyzing cellular and humoral immunity by expressing HPV E6 and E7 antigens, and influenza virus HA antigens in mRNA with various poly(A) structures showed no significant difference in T cell immunity and antibody titer. In conclusion, the addition of stable structures, such as a loop to the poly(A) tail, can significantly increase the expression efficiency and stability of mRNA, but the expression difference did not have as much of an impact on the immune response as expected.

Identifiers

PMID41249784
PMCPMC12623927

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.